| 发明名称 |
COMPOSITIONS FOR THE TREATMENT OF OSTOPOROSIS IN HUMANS |
| 摘要 |
A pharmaceutical composition for the alleviation or prevention of osteoporosis in a human patient, which comprises from about 10 mcg to about 40 mcg of 24,25(OH)2D3 in combination with from about 250 mg to about 750 mg of calcium in the form of a conventional dietary calcium supplement.
|
| 申请公布号 |
CA1340743(C) |
申请公布日期 |
1999.09.14 |
| 申请号 |
CA19890592701 |
申请日期 |
1989.03.03 |
| 申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD.;YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
发明人 |
EDELSTEIN SAMUEL;LADKANI DAVID;KADOSH SHAUL;SHALITA BENI;MAZOR ZE'EV;WEINER BEN ZION;MENCZEL JACOB |
| 分类号 |
A61K31/59;A61K33/06;A61K33/10;A61P3/02;A61P3/14;A61P43/00;(IPC1-7):A61K31/59 |
主分类号 |
A61K31/59 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
